Burkhard J. Otremba
Oldenburg, NI 26121, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Oncologic Outcomes of Young Breast Cancer Patients According to Tumor Biology.
Journal: Cancers
Published: February 19, 2025
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen.
Journal: International journal of clinical pharmacology and therapeutics
Published: April 05, 2024
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP.
Journal: Annals of hematology
Published: February 29, 2024
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study.
Journal: Annals of hematology
Published: September 30, 2023
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study.
Journal: Oncology research and treatment
Published: November 14, 2022
REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon®) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma.
Journal: Therapeutic advances in hematology
Published: July 20, 2022
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant.
Journal: Trials
Published: April 12, 2021
Patient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® Registry.
Journal: Journal of cancer research and clinical oncology
Published: January 21, 2021
Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany.
Journal: Future oncology (London, England)
Published: April 15, 2020
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.
Journal: BMC immunology
Published: March 17, 2020
Rare lymphomas in routine practice-Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms.
Journal: Hematological oncology
Published: November 25, 2019
Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany".
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 23, 2019
Last Updated: 09/26/2026